+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cryptococcosis Market - Global Forecast 2026-2032- Product Image
Cryptococcosis Market - Global Forecast 2026-2032- Product Image
New

Cryptococcosis Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083757
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior leaders in healthcare operating within infectious disease markets require precise, actionable intelligence to stay ahead in the evolving cryptococcosis market. This analysis equips decision-makers with deep insights and clear segmentation to support robust strategy, operational agility, and sustained market presence.

Market Snapshot: Cryptococcosis Market Size and Growth

The cryptococcosis market expanded from USD 6.87 billion in 2025 to USD 7.43 billion in 2026, demonstrating strong growth momentum. Projected to reach USD 12.66 billion by 2032 at a CAGR of 9.12%, this accelerated expansion reflects rising clinical demand, increased diagnostic adoption, and ongoing therapeutic innovation. Market growth is driven by upticks in global disease incidence, better access to care in emerging regions, and the continuous introduction of novel therapeutic strategies as care standards evolve.

Scope & Segmentation of the Cryptococcosis Market

  • Drug Classes: Encompass azoles (fluconazole, isavuconazole, itraconazole, posaconazole, voriconazole), echinocandins (anidulafungin, caspofungin, micafungin), polyenes, and pyrimidine analogues, supporting diverse clinical preferences and safety profiles.
  • Clinical Indications: Include cryptococcal meningitis, disseminated cryptococcosis, and pulmonary cryptococcosis—each presenting unique resource considerations and therapy pathways.
  • Administration Routes: Offer both intravenous alternatives for acute management and oral agents that increase access in community settings, underscoring the trend toward decentralized care.
  • End Users: Spanning ambulatory care centers, clinics, and hospitals, allowing for diverse prescribing patterns and procurement processes based on care delivery models.
  • Distribution Channels: Consist of hospital pharmacies, online platforms, and retail outlets, which play a pivotal role in shaping patient access and adherence across care settings.
  • Regions Covered: Americas, Europe, Middle East & Africa, and Asia-Pacific, representing a breadth of regulatory requirements, disease prevalence patterns, and market entry considerations.

Cryptococcosis Market: Key Takeaways for Strategic Leaders

  • Therapeutic portfolios now reflect greater diversity, with clinicians weighing efficacy against tolerance as both classic and novel antifungals come to the fore.
  • Advancements in diagnostics—including point-of-care and nucleic-acid-based methods—shift clinical practice toward earlier intervention and greater outpatient treatment utilization.
  • The adoption of outpatient parenteral therapies is transforming care dynamics, reducing inpatient demands and requiring coordinated clinical pathways for optimal delivery.
  • Policy and procurement priorities are focusing more sharply on supply robustness and evidence-based protocols to protect patient access as market complexity grows.
  • Strategic engagement in the cryptococcosis market demands a firm grasp of shifting segmentation, evolving supplier landscapes, and the nuances of regional market entry.

Tariff Impact on the Cryptococcosis Market

United States tariffs introduced in 2025 significantly reshaped supply chains and pricing frameworks across antifungal therapies in the cryptococcosis market. Manufacturers reinforced supplier networks, explored new sourcing relationships, and increased local production capacity where viable. Hospital systems responded by reassessing procurement practices, often pausing on new product implementation pending price stabilization. Regulatory and reimbursement structures were adapted to foster continuity of care, demonstrating the necessity for agile sourcing and transparent pricing to support market resilience and patient outcomes.

Methodology & Data Sources

This report consolidates findings from peer-reviewed scientific literature, regulatory submissions, manufacturer briefings, and direct insights from experts such as infectious disease clinicians and supply chain specialists. Rigorous cross-verification, including triangulation of multiple evidence sources, expert panel reviews, and alignment with the latest clinical guidelines, ensures high data reliability and actionable conclusions.

Why This Report Matters

  • Integrates epidemiological burden, therapeutic advances, and regional market differentiation to enable senior teams to develop comprehensive executive strategies.
  • Prepares leaders to proactively address procurement, patient access, and delivery hurdles by leveraging detailed segmentation and current market intelligence.
  • Delivers practical frameworks for commercial alignment, supply chain risk management, and stakeholder engagement specific to the cryptococcosis market landscape.

Conclusion

The cryptococcosis market demands heightened responsiveness and data-driven operational strategy as clinical and supply dynamics evolve. Leveraging in-depth insights and agile sourcing practices enables organizations to strengthen market resilience and ensure effective care delivery.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cryptococcosis Market, by Drug Class
8.1. Azoles
8.1.1. Fluconazole
8.1.2. Isavuconazole
8.1.3. Itraconazole
8.1.4. Posaconazole
8.1.5. Voriconazole
8.2. Echinocandins
8.2.1. Anidulafungin
8.2.2. Caspofungin
8.2.3. Micafungin
8.3. Polyenes
8.4. Pyrimidine Analogues
9. Cryptococcosis Market, by Indication
9.1. Cryptococcal Meningitis
9.2. Disseminated Cryptococcosis
9.3. Pulmonary Cryptococcosis
10. Cryptococcosis Market, by Route Of Administration
10.1. Intravenous
10.2. Oral
11. Cryptococcosis Market, by End User
11.1. Ambulatory Care Center
11.2. Clinic
11.3. Hospital
12. Cryptococcosis Market, by Distribution Channel
12.1. Hospital Pharmacy
12.2. Online Pharmacy
12.3. Retail Pharmacy
13. Cryptococcosis Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Cryptococcosis Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Cryptococcosis Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Cryptococcosis Market
17. China Cryptococcosis Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Astellas Pharma Inc.
18.7. B.M. Pharmaceuticals
18.8. Bausch Health Companies Inc.
18.9. Bayer AG
18.10. Bristol-Myers Squibb Company
18.11. Citron Pharma
18.12. Eisai Co., Ltd.
18.13. Gilead Sciences, Inc.
18.14. GlaxoSmithKline PLC
18.15. Glenmark Pharmaceuticals Limited
18.16. Johnson & Johnson Services, Inc.
18.17. Jolly Limited
18.18. Lunan Pharmaceutical Group
18.19. Matinas Biopharma Holdings, Inc.
18.20. Merck & Co., Inc.
18.21. Novartis AG
18.22. NuCare Pharmaceuticals, Inc.
18.23. Pfizer Inc.
18.24. Sanofi S.A.
18.25. Sigmapharm Laboratories, LLC
18.26. Skyepharma Production SAS
18.27. Sumitomo Pharma Co., Ltd.
18.28. Takeda Pharmaceutical Company Limited
18.29. Teva Pharmaceutical Industries Ltd.
18.30. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CRYPTOCOCCOSIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CRYPTOCOCCOSIS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CRYPTOCOCCOSIS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY FLUCONAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY FLUCONAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY FLUCONAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ISAVUCONAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ISAVUCONAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ISAVUCONAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ITRACONAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ITRACONAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ITRACONAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY POSACONAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY POSACONAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY POSACONAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY VORICONAZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY VORICONAZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY VORICONAZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ANIDULAFUNGIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ANIDULAFUNGIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ANIDULAFUNGIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CASPOFUNGIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CASPOFUNGIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CASPOFUNGIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY MICAFUNGIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY MICAFUNGIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY MICAFUNGIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY POLYENES, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY POLYENES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY POLYENES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PYRIMIDINE ANALOGUES, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PYRIMIDINE ANALOGUES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PYRIMIDINE ANALOGUES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CRYPTOCOCCAL MENINGITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CRYPTOCOCCAL MENINGITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CRYPTOCOCCAL MENINGITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISSEMINATED CRYPTOCOCCOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISSEMINATED CRYPTOCOCCOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISSEMINATED CRYPTOCOCCOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PULMONARY CRYPTOCOCCOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PULMONARY CRYPTOCOCCOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PULMONARY CRYPTOCOCCOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AMBULATORY CARE CENTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AMBULATORY CARE CENTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AMBULATORY CARE CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 111. EUROPE CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. EUROPE CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 113. EUROPE CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 114. EUROPE CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 115. EUROPE CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 116. EUROPE CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 117. EUROPE CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. EUROPE CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 127. AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 129. AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 130. AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 131. AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 132. AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 133. AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. ASEAN CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. ASEAN CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 146. ASEAN CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 147. ASEAN CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 148. ASEAN CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 149. ASEAN CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 150. ASEAN CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. ASEAN CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. GCC CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GCC CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 154. GCC CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 155. GCC CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 156. GCC CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 157. GCC CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 158. GCC CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. GCC CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. BRICS CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. BRICS CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 170. BRICS CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 171. BRICS CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 172. BRICS CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 173. BRICS CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 174. BRICS CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. BRICS CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. G7 CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. G7 CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 178. G7 CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 179. G7 CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 180. G7 CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 181. G7 CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 182. G7 CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. G7 CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 184. NATO CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. NATO CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 186. NATO CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 187. NATO CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 188. NATO CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 189. NATO CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 190. NATO CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. NATO CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 195. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 196. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 197. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 198. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 199. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 201. CHINA CRYPTOCOCCOSIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 202. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 203. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2032 (USD MILLION)
TABLE 204. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2032 (USD MILLION)
TABLE 205. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 206. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 207. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. CHINA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cryptococcosis market report include:
  • Abbott Laboratories
  • Astellas Pharma Inc.
  • B.M. Pharmaceuticals
  • Bausch Health Companies Inc.
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Citron Pharma
  • Eisai Co., Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Johnson & Johnson Services, Inc.
  • Jolly Limited
  • Lunan Pharmaceutical Group
  • Matinas Biopharma Holdings, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • NuCare Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Sigmapharm Laboratories, LLC
  • Skyepharma Production SAS
  • Sumitomo Pharma Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.43 Billion
Forecasted Market Value ( USD ) by 2032 $ 12.66 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Cryptococcosis Treatment Market - Global Forecast 2026-2032 - Product Image

Cryptococcosis Treatment Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Cryptococcosis Therapeutics - Global Strategic Business Report - Product Image

Cryptococcosis Therapeutics - Global Strategic Business Report

  • Report
  • 473 Pages
  • Global
From
Cryptococcosis Market Report 2025 - Product Image

Cryptococcosis Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Cryptococcosis Treatment - Global Strategic Business Report - Product Image

Cryptococcosis Treatment - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Cryptococcosis Therapeutics Market Report 2025 - Product Image

Cryptococcosis Therapeutics Market Report 2025

  • Report
  • 250 Pages
  • Global
From

About the Cryptococcosis Drug Market

Cryptococcosis is a fungal infection caused by the Cryptococcus neoformans and Cryptococcus gattii species. It is a serious infection that can affect the lungs, central nervous system, and other organs. Treatment of cryptococcosis typically involves antifungal medications, such as amphotericin B, fluconazole, and voriconazole. These drugs are used to treat both cryptococcal meningitis and cryptococcal pneumonia. The cryptococcosis drug market is a subset of the infectious diseases drug market. It is composed of antifungal medications used to treat cryptococcosis. These drugs are used to treat both cryptococcal meningitis and cryptococcal pneumonia. Some companies in the cryptococcosis drug market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.